Actavia Life Sciences, Inc.
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It also develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
No significant events in the past 90 days.